United States · FDA National Drug Code directory
ciprofloxacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66267-919_1fa773d7-02b2-11c3-e063-6394a90ac730
- Product NDC
- 66267-919
- Form
- TABLET
- Composition / generic term
- ciprofloxacin
- Labeler
- NuCare Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20040910
- Source listing expiry
- 20261231
Source-listed ingredients
- CIPROFLOXACIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BOTTLE (66267-919-06) · 66267-919-06
- 10 TABLET in 1 BOTTLE (66267-919-10) · 66267-919-10
- 21 TABLET in 1 BOTTLE (66267-919-21) · 66267-919-21
- 30 TABLET in 1 BOTTLE (66267-919-30) · 66267-919-30
- 60 TABLET in 1 BOTTLE (66267-919-60) · 66267-919-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →